WestBridge to Exit Star Health Stake
· news
WestBridge Begins Process to Exit Star Health Stake – Report
WestBridge Capital is preparing to exit its significant stake in Star Health and Allied Insurance after recently launching a general insurance company, Kiwi General Insurance. The move follows approval from the Insurance Regulatory and Development Authority of India (IRDAI) for Kiwi’s operations in November 2024.
According to Moneycontrol, WestBridge has approached investment banks to present proposals for a mandate to oversee the sale of its stake. JPMorgan is reportedly the preferred adviser. WestBridge holds approximately 40% of Star Health through Safecrop Investments India, a consortium set up by the private equity firm and late investor Rakesh Jhunjhunwala’s Madison Capital.
The regulatory landscape in India can be complex, and WestBridge appears to have been caught off guard by IRDAI’s licensing norms. As a promoter of both Star Health Insurance and Kiwi General Insurance, the company is now faced with the possibility of having to exit one of its investments due to regulatory requirements.
In 2018, WestBridge invested in Star Health along with consortium partners Madison Capital and Rakesh Jhunjhunwala, acquiring a significant majority stake. The investment was seen as a strategic move by WestBridge to tap into India’s growing health insurance market.
The exit strategy for WestBridge is far from clear, with multiple options being explored. These include finding a strategic buyer or selling shares through the secondary market. With its significant stake in Star Health, this will be a challenging task. Prudential’s decision to relinquish its promoter status in ICICI Prudential after acquiring a 75% stake in Bharti Life Insurance serves as an example.
Star Health Insurance has stated that any decision relating to a shareholder’s investment is entirely the responsibility of the shareholder. The company remains focused on executing its business strategy, but this statement only adds to the confusion surrounding the situation.
As investors and regulators continue to navigate India’s insurance sector, WestBridge’s exit from Star Health will have significant implications for the company and the broader market. Regulatory requirements in India are often criticized for being unclear or ambiguous, leaving companies like WestBridge in a state of uncertainty.
The Indian government has been actively working to simplify the regulatory framework and create a more conducive environment for businesses to operate. The exit strategy for WestBridge will undoubtedly be closely watched by investors and analysts, who are eager to see how the company navigates this complex situation.
WestBridge’s decision highlights the complexities of regulatory compliance in India’s insurance sector. As companies like Kiwi General Insurance begin to operate, it is clear that the industry will continue to evolve and adapt to changing regulatory requirements.
Reader Views
- CMColumnist M. Reid · opinion columnist
The regulatory maze is getting too hot for WestBridge. Its move to exit Star Health might be more about navigating IRDAI's complex licensing norms than maximizing returns. By launching Kiwi General Insurance, WestBridge has inadvertently created a conflict of interest. As a promoter of both companies, it's now forced to choose between its stake in Star Health and compliance with regulatory requirements. This raises questions about the long-term viability of such investments in India's health insurance market, where regulatory frameworks are constantly evolving.
- EKEditor K. Wells · editor
WestBridge's stake in Star Health is set to change hands, and this development should raise concerns about the exit strategies of private equity firms operating in India's insurance sector. While the regulatory landscape can be complex, WestBridge appears to have been caught off guard by IRDAI's licensing norms. The key question now is how will WestBridge monetize its 40% stake, given Star Health's limited public float and regulatory constraints? Will we see a strategic buyer emerge or a messy sale through the secondary market?
- CSCorrespondent S. Tan · field correspondent
WestBridge's hasty entry into the Indian general insurance market through Kiwi may have set off a chain reaction that now threatens its significant stake in Star Health Insurance. By launching Kiwi, WestBridge has inadvertently triggered IRDAI regulations that limit promoter status to companies with specific business lines. The regulatory complexities have caught up with WestBridge, forcing it to explore an exit strategy. While the company's move into general insurance may have been a strategic gamble, its execution appears to be a costly miscalculation.